Torrente-Segarra V, Lisbona-Pérez Mp, Rotes-Sala D, Castro-Oreiro S, Carbonell-Abelló J
Reumatólogo, Servicio de Reumatología Hospital del Mar - IMAS (Barcelona) Paseo Marítimo 23-25, 08003 Barcelona, Spain.
Lupus. 2009 Mar;18(3):270-2. doi: 10.1177/0961203308095001.
Systemic lupus erythematosus (SLE) is a multiorganic autoimmune disease that affects skin, osteoarticular and kidney frequently. Rituximab showed efficacy in treatment of osteoarticular and haematological SLE, but its use has been generalised for renal disease. In our case, we showed efficacy of rituximab in SLE articular disease, showing an ultrasonographic improvement.
系统性红斑狼疮（SLE）是一种多器官自身免疫性疾病，常累及皮肤、骨关节和肾脏。利妥昔单抗在治疗骨关节型和血液型SLE方面显示出疗效，但其在肾脏疾病中的应用已得到广泛推广。在我们的病例中，我们展示了利妥昔单抗在SLE关节疾病中的疗效，显示出超声检查结果的改善。
